Lost Money on KBR, Inc.(KBR)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky — Neutral
KBR GlobeNewsWire — November 17, 2025NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in KBR, Inc. ("KBR, Inc." or the "Company") (NYSE: KBR) of a class action securities lawsuit.
Levi & Korsinsky Notifies Shareholders of WPP plc(WPP) of a Class Action Lawsuit and an Upcoming Deadline — Neutral
WPP GlobeNewsWire — November 17, 2025NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in WPP plc ("WPP" or the "Company") (NYSE: WPP) of a class action securities lawsuit.
Investors in Cytokinetics, Incorporated Should Contact Levi & Korsinsky Before November 17, 2025 to Discuss Your Rights – CYTK — Neutral
CYTK GlobeNewsWire — November 17, 2025NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) of a class action securities lawsuit.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 5, 2026 in Inspire Medical Systems, Inc. Lawsuit – INSP — Neutral
INSP GlobeNewsWire — November 17, 2025NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Inspire Medical Systems, Inc. ("Inspire Medical Systems, Inc." or the "Company") (NYSE: INSP) of a class action securities lawsuit.
Buffett's Google bet comes 2 decades after billionaire investor 'inspired' search giant's IPO — Positive
GOOG GOOGL CNBC — November 17, 2025Warren Buffett's Berkshire Hathaway revealed late Friday that it owns a $4.3 billion stake in Google parent Alphabet as of the end of the third quarter. Alphabet shares rallied on Monday and are now up about 50% this year, driven in part by the artificial intelligence boom.
Nuvalent, Inc. (NUVL) Discusses Topline Pivotal Data From ALKOVE-1 Trial of Neladalkib in ALK-Positive Non-Small Cell Lung Cancer Transcript — Neutral
NUVL Seeking Alpha — November 17, 2025Nuvalent, Inc. ( NUVL ) Discusses Topline Pivotal Data From ALKOVE-1 Trial of Neladalkib in ALK-Positive Non-Small Cell Lung Cancer November 17, 2025 8:00 AM EST Company Participants Chelcie Lister James Porter - CEO, President & Director Christopher Turner - Chief Medical Officer Alexandra Balcom - CFO & Treasurer Darlene Noci - Chief Development Officer Conference Call Participants Bradley Canino - Guggenheim Securities, LLC, Research Division Marc Frahm - TD Cowen, Research Division Laura Prendergast - Stifel, Nicolaus & Company, Incorporated, Research Division Anupam Rama - JPMorgan Chase & Co, Research Division Andrew Berens - Leerink Partners LLC, Research Division …
Investors in CarMax, Inc. Should Contact Levi & Korsinsky Before January 2, 2026 to Discuss Your Rights – KMX — Neutral
KMX GlobeNewsWire — November 17, 2025NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in CarMax, Inc. ("CarMax, Inc." or the "Company") (NYSE: KMX) of a class action securities lawsuit.
The memory boom has been great for Micron — but could hurt these other tech stocks — Positive
MU Market Watch — November 17, 2025Morgan Stanley analysts are getting worried about potential profit pressure at Dell and HP due to surging memory prices.
Why Dell Technologies Stock is Plunging to Lead S&P 500 Decliners Monday — Negative
DELL Investopedia — November 17, 2025The artificial intelligence boom that's sent memory chip prices soaring is hurting computer hardware makers, according to a report from Morgan Stanley, which downgraded some of the biggest names in the sector.
2 EV Stocks Gapping Lower on Earnings, Bear Note — Negative
LCID XPEV Schaeffers Research — November 17, 2025Electric vehicle (EV) stock Xpeng Inc (NYSE:XPEV) is down 9.4% to trade at $22.67 at last check, brushing of a bottom-line win for the third quarter as well as record deliveries, after the company issued a dismal fiscal fourth-quarter outlook amid fierce competition.
TAT Technologies: When Expectations Are High, Earnings Execution Has To Be Tip-Top — Positive
TATT Seeking Alpha — November 17, 2025TAT Technologies, a leading provider of thermal solutions, aircraft APU services, and landing gear, has generated returns of 56% on a YTD basis and comfortably outperformed its peers. Q3 results met expectations, but the pace of revenue growth continues to slow, and the backlog failed to progress. TATT's balance sheet now looks robust, supporting potential M&A, and the company's underdeveloped FCF profile is on the up.
Ford turns to Amazon to give used cars sales a boost — Positive
AMZN F TechCrunch — November 17, 2025One year ago, e-commerce giant Amazon kicked off its new online car sales business with Hyundai. Now, Ford is joining in with a certified used car twist.
WPP DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages WPP plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - WPP — Neutral
WPP GlobeNewsWire — November 17, 2025NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADS” or “ADSs”) of WPP plc (NYSE: WPP) between February 27, 2025 and July 8, 2025, both dates inclusive (the “Class Period”), of the important December 8, 2025 lead plaintiff deadline.
Google shares hit record after Buffett's Berkshire surprise investment — Positive
BRK-A BRK-B GOOG GOOGL Fox Business — November 17, 2025Google stock hits all-time high as Berkshire Hathaway reveals $4 billion investment, marking Warren Buffett's rare tech bet and endorsement of AI efforts.
ROSEN, A LONGSTANDING LAW FIRM, Encourages Stride, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - LRN — Neutral
LRN Newsfile Corp — November 17, 2025New York, New York--(Newsfile Corp. - November 17, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Stride, Inc. (NYSE: LRN) between October 22, 2024 and October 28, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.
Nvidia's earnings to be key validation moment for AI sector, Wedbush believes — Positive
NVDA Proactive Investors — November 17, 2025Nvidia Corp (NASDAQ:NVDA, XETRA:NVD) will report its latest quarterly results after the market close on Wednesday, and analysts at Wedbush believe investors across the technology sector will be closely watching the update as a barometer for broader AI demand. The analysts believe that with tech stocks experiencing volatility and renewed concerns about an “AI bubble,” the focus this week “comes down to gauging the AI Revolution demand story which starts and ends with Nvidia.
WPP plc: Looking At Upside Post-AI Impact (With Takeover News) — Neutral
WPP Seeking Alpha — November 17, 2025WPP plc is deeply undervalued, trading at a 4.4x P/E, despite recent operational setbacks and sector-wide headwinds. WPP faces execution risk, client losses, and a likely 50% dividend cut, but remains a fundamentally sound, IG-rated business with turnaround potential. My price target for WPP stock is lowered, reflecting a more conservative outlook, but I reiterate a Buy rating for risk-tolerant investors.
Can the 3Cloud Acquisition Push Cognizant Stock Higher in 2025? — Positive
CTSH Zacks Investment Research — November 17, 2025CTSH deepens its AI and Azure capabilities with the planned 3Cloud acquisition, adding expertise, certifications, and new sector clients.
LATAM (LTM) Reports Q3 Earnings: What Key Metrics Have to Say — Neutral
LTM Zacks Investment Research — November 17, 2025While the top- and bottom-line numbers for LATAM (LTM) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TLX — Neutral
TLX Newsfile Corp — November 17, 2025New York, New York--(Newsfile Corp. - November 17, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the "Class Period").